Revance Therapeutics Inc. buy Maxi_Scalibusa
Start price
17.02.19
/
50%
€15.82
Target price
03.04.19
€27.06
Performance (%)
-14.60%
End price
03.04.19
€13.51
Summary
This prediction ended on 03.04.19 with a price of €13.51. The prediction for Revance Therapeutics Inc. disappointed with a performance of -14.60%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by Maxi_Scalibusa for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Revance Therapeutics
(Stop Loss Kurs erreicht)


